Dr. Michael Hagensee, MD

Claim this profile

University Medical Center New Orleans

Studies HIV/AIDS
Studies Anal Intraepithelial Neoplasia
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
University Medical Center New Orleans
Image of trial facility.
Louisiana State University Health Sciences Center - New Orleans

Clinical Trials Michael Hagensee, MD is currently running

Image of trial facility.

HPV Vaccine

for HIV/AIDS

The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adults with well-controlled HIV infection. The secondary objective of the study is to observe short term clinical outcomes of prevalent HPV genotype-specific anogenital infections in adults living with HIV who complete the three-dose Gardasil-9 vaccine series. The clinical hypothesis is that adults with virologically controlled HIV mount a serum antibody response to the nonavalent HPV vaccine that is comparable to HIV negative counterparts. We also postulate that HPV vaccination will provide short-term clinical benefit against HPV infections and disease associated with vaccine genotypes.
Recruiting4 awards Phase 4

More about Michael Hagensee, MD

Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Hagensee, MD has experience with
  • Human Papillomavirus 9-valent Vaccine, Recombinant
  • Fluorouracil
  • Imiquimod
Breakdown of trials Michael Hagensee, MD has run
HIV/AIDS
Anal Intraepithelial Neoplasia
Infections and Infestations
Human Papillomavirus Infection
Cervical Dysplasia

Other Doctors you might be interested in

JoshiSherman Clinical Research
Scott E. DelacroixLSU Healthcare Network/Metairie Multi-Specialty Clinic
Rajasree P. ChowdryUniversity Medical Center New Orleans

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Hagensee, MD specialize in?
Michael Hagensee, MD focuses on HIV/AIDS and Anal Intraepithelial Neoplasia. In particular, much of their work with HIV/AIDS has involved treating patients, or patients who are undergoing treatment.
Is Michael Hagensee, MD currently recruiting for clinical trials?
Yes, Michael Hagensee, MD is currently recruiting for 1 clinical trial in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Michael Hagensee, MD has studied deeply?
Yes, Michael Hagensee, MD has studied treatments such as Human papillomavirus 9-valent vaccine, recombinant, Fluorouracil, Imiquimod.
What is the best way to schedule an appointment with Michael Hagensee, MD?
Apply for one of the trials that Michael Hagensee, MD is conducting.
What is the office address of Michael Hagensee, MD?
The office of Michael Hagensee, MD is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top